Daan W. Notermans

Oct 31, 2023 | wwwnc.cdc.gov | Daan W. Notermans |Cornelia C.H. Wielders |Jeroen Bos |Sandra Witteveen

Marlies Mulder, Daan W. Notermans, Cornelia C.H. Wielders, Jeroen Bos, Sandra Witteveen, Varisha A. Ganesh, Fabian Landman, Angela de Haan, Caroline Schneeberger-van der Linden, Antoni P.A. Hendrickx , and on behalf of the Dutch CPE Surveillance Study Group1 Author affiliations: Maastricht University Medical Center+, Maastricht, the Netherlands (M. Mulder); National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands (M. Mulder, D.W. Notermans, C.C.H. Wielders, J.

Sep 12, 2023 | nature.com | Leo Schouls |Sandra Witteveen |Fabian Landman |Daan W. Notermans

AbstractAlthough the Netherlands is a country with a low endemic level, methicillin-resistant Staphylococcus aureus (MRSA) poses a significant health care problem. Therefore, high coverage national MRSA surveillance has been in place since 1989. To monitor possible changes in the type-distribution and emergence of resistance and virulence, MRSA isolates are molecularly characterized.